Sionna Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | -40.5% | +257.6% | +75.5% | |
| – | -53.2% | +285.1% | +59.9% | |
| – | -29.8% | -1.9% | +54.7% | |
| – | -53.4% | +283.0% | +59.9% | |
| – | +6.1% | +109.5% | -94.5% | |
| – | -2.6% | +29.7% | +12.4% | |
| – | – | +47.3% | +18.4% | |
| – | +29.1% | +65.0% | -35.2% | |
| – | – | – | – | |
| – | – | – | – | |
| – | +0.0% | +0.0% | -9.4% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.